Receptor Activator of NF-κB (RANK) Confers Resistance to Chemotherapy in AML and Associates with Dismal Disease Course
暂无分享,去创建一个
P. Schneider | H. Salih | Bastian J. Schmied | J. Heitmann | Claudia Tandler | Kim L. Clar | L. Weber | M. Marconato | Jonas S. Heitmann | C. Tandler